578 Results (Page 1 of 24)
Canada Markets Research Reports
Canada Bioinformatics Market Analysis
The Canada Bioinformatics market is projected to grow from $1.23 Bn in 2022 to $4.11 Bn by 2030, registering a CAGR of 16.30% during the forecast period of 2022 - 2030. The main factors driving the growth would be robust infrastructure for research and development, government funding, and a collaborative market. The market is segmented by technology and by application. Some of the major players include DNAstack (CAN), Bioinformatics Solutions Inc (CAN), ThermoFisher Scientific, Agilent Technologies, Celera Corporation.
Canada Head and Neck Cancer Therapeutics Market Analysis
The Canada Head and Neck Cancer Therapeutics Market was valued at $97.60 Mn in 2023 and is predicted to grow at a CAGR of 12.50% from 2023 to 2030, to $222.60 Mn by 2030. The key drivers of this industry include the rising incidence of Head and Neck cancer, advancements in treatment options, and government support. The industry is primarily dominated by players such as AstraZeneca, Pfizer, Eli Lilly and Company, Bristol Myers Squibb, Merck, Sanofi, Roche, Takeda Pharmaceutical Company Limited, Teva Pharmaceuticals, and AbbVie.
Canada Financial Assistance Programs Market Analysis
The Canada Financial Assistance Programs Market was valued at $2,267.1 Mn in 2023 and is projected to grow at a CAGR of 14.6% from 2023 to 2023, to $5,885.3 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Merck, GSK, Johnson & Johnson, Novartis among others.
Canada Bio-implant Market Analysis
The Canada Bio-implant Market was valued at $5200 Mn in 2023 and is predicted to grow at a CAGR of 5.9% from 2023 to 2030, to $7767.4 Mn by 2030. The Canada Bio-implant Market is growing due to Aging population, Prevalence of chronic diseases, and Healthcare Expenditure. The market is primarily dominated by players such as Stryker Corporation, Zimmer Biomet, Medtronic, Boston Scientific Corporation, Johnson & Johnson Services.
Canada Bariatric Surgery Devices Market Analysis
The Canada Bariatric Surgery Devices Market was valued at $212.8 Mn in 2023 and is projected to grow at a CAGR of 5.2% from 2023 to 2023, to $303.4 Mn by 2030. Major factors driving the market for bariatric surgical devices include the rising incidence of adult obesity brought on by altered lifestyle patterns and excessive calorie consumption. The demand for bariatric operations is also anticipated to rise over the forecast period due to increased government backing and growing public awareness of the market's unhealthy food and beverage offerings and how they affect BMI, thus driving the market growth of the Bariatric Surgery Devices. The prominent players in the market are Medtronic, B. Braun, Asenus Surgical, Johnson & Johnson, Cousin Surgery among others.
Canada Medical and Diagnostic Laboratory Service Market Analysis
This report presents a strategic analysis of the Canada Medical and Diagnostic Laboratory Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Canada Medical and Diagnostic Laboratory Service Market, offering unmatched value, accuracy and expert insights.
Canada Liver Disease Drugs Market Analysis
This report presents a strategic analysis of the Canada Liver Disease Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Canada Liver Disease Drugs Market, offering unmatched value, accuracy and expert insights.
Canada Advanced Therapy Medicinal Products (ATMPs) Market Analysis
Canada's Advanced Therapy Medicinal Products (ATMPs) market is likely to grow at a CAGR of 13% from a market size of $0.81 Bn in 2022 to $2.15 Bn in 2030. The major growth drivers driving the market are the increasing prevalence of chronic diseases and the growing investment in the industry. This report is segmented by product type, disease type, and by distribution channel. Some key players in this market include Novartis, Celgene Corporation, Gilead Lifesciences, Bluebird Bio, and others.
Canada Clinical Trials Support Service Market Analysis
This report presents a strategic analysis of the Canada Clinical Trials Support Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Canada Clinical Trials Support Service Market, offering unmatched value, accuracy and expert insights.
Canada Hemodialysis Vascular Grafts Market Analysis
Canada Hemodialysis Vascular Grafts Market was valued at $16.76 Bn in 2023 and is predicted to grow at a CAGR of 5.1 % from 2023 to 2030, to $23.74 Bn by 2030. The key drivers of this industry include the Rising prevalence of chronic kidney disease, the aging population, and technological advancements. The industry is primarily dominated by W. L. Gore, C. R. Bard, Vascudyne, and LeMaitre among others.
Canada Contact Lenses Market Analysis
Canada Contact Lenses Market was valued at $1,371.20 Mn in 2023 and is predicted to grow at a CAGR of 8.9% from 2023 to 2030, to $2,490.55 Mn by 2030. The key drivers of this industry include the rising prevalence of myopia, increased adoption of convenience and aesthetics, and technological advancements. The industry is primarily dominated by Bausch and Lomb, CooperVision, Alcon Vision, and Essilor among others.
Canada Retail Pharmacy Market Analysis
This report presents a strategic analysis of the Canada Retail Pharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Canada Retail Pharmacy Market, offering unmatched value, accuracy and expert insights.
Canada Dental Service Market Analysis
Canada Dental Service Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Dental Services is expanding as a result of increasing oral diseases like dental caries, periodontal diseases and oral cancer. Increasing demand for cosmetic dentistry, dental implants and oral diseases are fueling the Dental Service Market. Some of the key players in the global Dental Service Market are Smile 360, Pacific Dental Services, Dental Services Group, Axiss Dental, Q & M Dental Group, Apollo White Dental, Coast Dental, Gentle Dental of New England, Abano Healthcare Group, Healthway Medical Corporation.
Canada In Vitro Fertilization (IVF) Service Market Analysis
In Vitro Fertilization (IVF) is a complex assisted reproductive technology (ART) designed to facilitate conception by fertilizing an egg outside the body. The procedure starts with ovarian stimulation to produce multiple eggs, which are then collected and mixed with sperm in a lab. Once fertilization occurs, the resulting embryo is transferred into the woman's uterus in hopes of achieving pregnancy. IVF is typically pursued when other fertility treatments have failed or when specific fertility issues, such as blocked fallopian tubes, endometriosis, or low sperm count, are present.
Canada Cancer Pain Management Market Analysis
Canada's Cancer Pain Management market is projected to grow from $521.6 Mn in 2022 to $788.43 Mn by 2030, registering a CAGR of 5.3 % during the forecast period of 2022 - 2030. The main factors driving the growth would be an increase in cancer cases, advancements in pain management technologies and treatment, and government support and initiatives. The market is segmented by drug type and by disease. Some of the major players include WEX Pharmaceuticals (CAN), Tetra Bio-Pharma (CAN), Pfizer, Teva Pharmaceuticals, and Medtronic.
Canada Dilated Cardiomyopathy Therapeutics Market Analysis
Canada Dilated Cardiomyopathy Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. The phrase "dilated cardiomyopathy" refers to conditions that affect the heart muscle and is regarded as a deadly cardiac condition. Reduced myocardial contractility and left and right ventricular dilatation are usually its defining characteristics. The potential driving force behind the DCM Therapeutics Market has been the rise in diagnostic alterations and symptom awareness, as well as declining dietary and lifestyle choices that have led to an increase in the occurrence of disease. The government is sponsoring research and development (R&D) projects to encourage scientists and pharmaceutical firms to create novel treatments. Array BioPharma, Inc., AstraZeneca plc, Celladon Corporation, GlaxoSmithKline plc, Janssen Pharmaceuticals, Inc. (J&J), Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Vericel Corporation, and many others are key players in the market for cystic fibrosis (CF) therapeutics.
Canada Mucopolysaccharidosis I (MPS-I) Therapeutics Market Analysis
Canada Mucopolysaccharidosis I (MPS-I) therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. Rising consumer awareness, new drug approvals, enticing reimbursement plans, an established healthcare system, and the presence of sizable market competitors all drive the market for treating Mucopolysaccharidosis I. Major global players in this market are Takeda Pharmaceutical Company Limited, BioMarin Pharmaceuticals, Inc., Ultragenyx Pharmaceutical Inc., Sarepta Therapeutics, Abeona Therapeutics, Eloxx Pharmaceuticals, Esteve, Immusoft Corporation, Inventiva, GC Pharma, JCR Pharmaceuticals Co Ltd., RegenxBio Inc., Sangamo Therapeutics, Inc., Bioasis Technologies Inc., and Paradigm Biopharmaceuticals Ltd.
Canada Spinal Muscular Atrophy (SMA) Therapeutics Market Analysis
Canada Spinal Muscular Atrophy (SMA) Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. The market is expanding as a result of rising SMA instances, technological advancements, government encouragement, rising consumer awareness, and increased R&D activities. Major global players in Spinal Muscular Atrophy (SMA) Therapeutics Market are Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland), Boehringer Ingelheim International GmbH. (Germany), GSK plc (U.K.), Novartis AG (Switzerland), Biogen (U.S.), Pfizer Inc.(U.S.), Ionis Pharmaceuticals, Inc. (U.S.), Regeneron Pharmaceuticals Inc (U.S.)., Abbott (U.S.), AbbVie Inc. (U.S.), Novo Nordisk A/S (Denmark), Takeda Pharmaceutical Company Limited (Japan), AstraZeneca (U.K.), Leadiant Biosciences, Inc.(Italy), Catalyst Pharmaceuticals, Inc.(U.S.), PTC Therapeutics (U.S.)
Canada PET Scan Market Analysis
The Canada PET Scan Market was valued at $155.2 Mn in 2023 and is predicted to grow at a CAGR of 5.4% from 2023 to 2030, to $224.3 Mn by 2030. The key drivers of the market include the rising prevalence of chronic diseases, rising demand for non-invasive diagnostic devices, and increased demand for early diagnosis. The prominent players of the Canada PET Scan Market are GE Healthcare, Hitachi, Siemens Healthineers, Toshiba, and Canon Medical Systems, among others.
Canada Adrenoleukodystrophy (ALD) Therapeutics Market Analysis
Canada Adrenoleukodystrophy (ALD) Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. Drivers of acromegaly market are increasing cases of the disorder which in turn increased awareness and government focus motivated financial support to R&D. Poxel SA, Bluebird Bio Inc.,Viking Technologies, Minoryx Therapeutics sl., Apteeus SAS, Ashvattha Therapeutics LLC, NeuroVia Company, Autobahn Therapeutics Inc., Aldagen Inc., Celularity Inc., Imstem Biotechnology Inc., MedDay SA, and Orpheris Inc. are major competitors in the Canada Adrenoleukodystrophy (ALD) drugs market.
Canada Electronic Health Records Market Analysis
The Canada Electronic Health Records market size was valued at $2.26 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 4% from 2022 to 2030 and will reach $3.09 Bn in 2030. Canada's EHR market growth can be attributed to the surging need for remote monitoring and chronic disease management. The market is segmented by product type, application type, and end user. The key market players are Allscripts, Cerner, Epic Systems, and others.
Canada Primary Hyperoxaluria (PH) Therapeutics Market Analysis
Canada Primary Hyperoxaluria (PH) Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. One of the key factors propelling the growth of the hyperoxaluria drug market is the rise in the number of persons with the condition worldwide. The regulatory body's extension of special designations and rising consumer demand for medications including thiazide diuretics, calcium oxalate urinary inhibitors, and others to address a variety of health issues both contribute to the market's quick growth. Major global players in Primary Hyperoxaluria (PH) Therapeutics Market are Allena Pharmaceuticals, Inc., Intellia Therapeutics, Inc., OxThera, Dicerna Pharmaceuticals, Inc, Alnylam Pharmaceuticals, Inc., Pfizer Inc., and Sanofi.
Canada Dermatological Therapeutics Market Analysis
Canada Dermatological Therapeutics Market is at around $3.28 Bn in 2023 and is projected to reach $5.84 Bn in 2030, exhibiting a CAGR of 8.6% during the forecast period. The market is growing due to factors such as the rising prevalence of skin disorders, the aging population, and technological developments. The market is dominated by key players like Almirall SA, Pfizer Inc., AbbVie Inc., Amgen, Gladerma SA, Johnson & Johnson, Novartis AG, Eli Lily and Company, Sun Pharmaceuticals Ltd., and GlaxoSmithKline PLC.
Canada Dental Caries Detectors Market Analysis
The Canada Dental Caries Detectors Market was valued at $18.3 Mn in 2023 and is predicted to grow at a CAGR of 8.9% from 2023 to 2030, to $33.2 Mn by 2030. Canada Dental Caries Detectors Market is growing due to Lifestyle changes, Rising awareness, and Advanced imaging and diagnostic. The market is primarily dominated by players such as Dentalcorp Holdings Ltd., 123Dentist, Altima Dental Canada Holdings Inc.Sirona Dental Systems, Dentsply Sirona, KaVo Kerr, Ivoclar Vivadent, Planmeca Oy, Adec Technologies, 3M ESPE, Morita Corporation.
Canada Clinical Nutrition for Diabetes Care Market Analysis
The Canada Clinical Nutrition for Diabetes Care Market was valued at $172 Mn in 2023 and is predicted to grow at a CAGR of 4.78% from 2023 to 2030, to $238.49 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Abbott Nutrition, Eli Lily, Danone, AgaMatrix Inc., and among others.
